ATC codes:
P01BF09
EMLc
Indication
Malaria due to Plasmodium vivax
ICD11 code:
1F81
INN
Artesunate + sulfadoxine + pyrimethamine
Medicine type
Chemical agent
List type
Core
(EML)
(EMLc)
(EMLc)
Formulations
Oral > Solid > tablet:
50 mg [3] + 500 mg + 25 mg [1] in copackage (scored)
EML status history
First added in 2025
(TRS
1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Wikipedia
Summary of evidence and Expert Committee recommendations
Following the review of the age appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of a co-packaged formulation of artesunate and sulfadoxine + pyrimethamine on the EML and EMLc, noting that this presentation would replace the separate listings of artesunate 50 mg tablets and sulfadoxine + pyrimethamine 500 mg + 25 mg tablets which are recommended for deletion.